Understanding modern-day vaccines: what you need to know

  title={Understanding modern-day vaccines: what you need to know},
  author={Volker Vetter and G{\"u}lhan Denizer and Leonard R Friedland and Jyothsna Krishnan and Marla Shapiro},
  journal={Annals of Medicine},
  pages={110 - 120}
Abstract Vaccines are considered to be one of the greatest public health achievements of the last century. Depending on the biology of the infection, the disease to be prevented, and the targeted population, a vaccine may require the induction of different adaptive immune mechanisms to be effective. Understanding the basic concepts of different vaccines is therefore crucial to understand their mode of action, benefits, risks, and their potential real-life impact on protection. This review aims… 

Principles in Immunology for the Design and Development of Vaccines.

Vaccinology has come a long way from early, empirically developed vaccines to modern vaccines rationally designed and produced, which has opened up the potential of extending its application to hitherto not accessible complex microbial pathogens plus providing new immunotherapies to tackle diseases such as cancer, Alzheimer's disease, and autoimmune disease.

Vaccines and vaccination: history and emerging issues

Key historical lessons learned with prophylactic vaccines are examined with reflections on current healthcare dilemmas and controversies with respect to influenza and COVID-19 vaccines.

Membrane Microvesicles as Potential Vaccine Candidates

This review focuses on the mechanisms of microvesicle biogenesis and the role ofmicrovesicles in infectious diseases, and the application ofMicrovesicles as a novel and effective vaccine delivery system.

Emerging trends of edible vaccine therapy for combating human diseases especially COVID‐19: Pros, cons, and future challenges

The researchers are still doing efforts to develop an effective, reliable, and easily accessible vaccine candidate to protect against COVID‐19, and the use of plant‐based edible vaccines is an emerging trend as it possesses minimum or no side effects compared with synthetic vaccines.

COVID-19: Insights into Potential Vaccines

This review aims to discuss the different vaccine platforms and the clinical trials of the candidate vaccines developed with the release of the genetic sequence of the SARS-CoV-2 virus in January.

Immune Response Induced by Immunisation with Antiviral Vaccines

The need for further research is highlighted to increase the efficiency of vaccination and one of potential solutions is the use of adjuvants based on recombinant human cytokines, as well as specific aspects of immune response development depending on the nature of a specific antigen.

Nanoparticles as Vaccines to Prevent Arbovirus Infection: A Long Road Ahead

A roadmap is proposed to help researchers better characterize and evaluate nanovaccines against medically important arboviruses and indicate that nanoparticles have great potential for use as a new vaccine system againstArthropod-borne viruses.

Nasal vaccine as a booster shot: a viable solution to restrict pandemic?

The results showed that the nasal vaccines were both effective and protective according to the current researches approaching during the COVID-19 period and the preclinical and clinical phase trials prove the intranasal vaccination elicits more robust and cross-protective immunity than conventional vaccines.

Vaccine design and delivery approaches for COVID-19




Vaccines for the 21st century

The state of the art of recent clinical trials of vaccines for major unmet medical needs such as HIV, malaria, TB, and cancer are reviewed and the innovative technologies currently used in vaccine research and development including adjuvants, vectors, nucleic acid vaccines, and structure‐based antigen design are described.

Vaccine Adjuvants: from 1920 to 2015 and Beyond

Adjuvants are the most advanced new technology in the search for new vaccines against challenging pathogens and for vulnerable populations that respond poorly to traditional vaccines.

Vaccine development: From concept to early clinical testing.

DNA vaccines: roles against diseases.

DNA vaccines against cancer, tuberculosis, Edwardsiella tarda, HIV, anthrax, influenza, malaria, dengue, typhoid and other diseases were explored and advantages and disadvantages have been explained.

Vaccine impact: Benefits for human health.

Vaccines, new opportunities for a new society

Overall, vaccines have done and continue to do an excellent job in eliminating or reducing the impact of childhood diseases and have the potential to make an enormous contribution to the health of modern society by preventing and treating not only communicable diseases in all ages, but also noncommunicable diseases such as cancer and neurodegenerative disorders.

Vaccine immunology

A review of immunology is provided to enhance understanding of vaccine efficacy and use, and elaborates on the immune response to vaccination.

Current and next generation influenza vaccines: Formulation and production strategies.

Developing vaccines in the era of genomics: a decade of reverse vaccinology.

  • K. SeibX. ZhaoR. Rappuoli
  • Biology
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
  • 2012
Genomics has catalysed a shift in vaccine development towards sequence-based 'Reverse Vaccinology' approaches, which use high-throughput in silico screening of the entire genome of a pathogen to identify genes that encode proteins with the attributes of good vaccine targets.